➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Medtronic
Harvard Business School
Express Scripts

Last Updated: June 16, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Phenylacetic acid


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Phenylacetic acid?

Phenylacetic acid is an investigational drug.

There have been 5 clinical trials for Phenylacetic acid. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2017.

The most common disease conditions in clinical trials are Disease, Drug-Related Side Effects and Adverse Reactions, and Urea Cycle Disorders, Inborn. The leading clinical trial sponsors are Shijiazhuang Yiling Pharmaceutical Co. Ltd, Yiling Pharmaceutical Inc., and Horizon Pharma Ireland, Ltd., Dublin Ireland.

There are two US patents protecting this investigational drug and forty international patents.

Recent Clinical Trials for Phenylacetic acid
TitleSponsorPhase
A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in ChinaShijiazhuang Yiling Pharmaceutical Co. LtdPhase 3
A Phase I Clinical Study Trial of Felbinac Trometamol Injection in ChinaShijiazhuang Yiling Pharmaceutical Co. LtdPhase 1
Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle DisordersHorizon Therapeutics, LLCPhase 4

See all Phenylacetic acid clinical trials

Clinical Trial Summary for Phenylacetic acid

Top disease conditions for Phenylacetic acid
Top clinical trial sponsors for Phenylacetic acid

See all Phenylacetic acid clinical trials

US Patents for Phenylacetic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Phenylacetic acid   Get Started Free Compounds for the treatment of infectious diseases Hoffmann-La Roche Inc. (Little Falls, NJ)   Get Started Free
Phenylacetic acid   Get Started Free Ketene imine compound, polyester film, back sheet for solar cell module, and solar cell module FUJIFILM Corporation (Tokyo, JP)   Get Started Free
Phenylacetic acid   Get Started Free 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists Bristol-Myers Squibb Company (Princeton, NJ)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Phenylacetic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Phenylacetic acid China CN107001386 2034-10-11   Get Started Free
Phenylacetic acid European Patent Office EP3204392 2034-10-11   Get Started Free
Phenylacetic acid Japan JP2017531655 2034-10-11   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Boehringer Ingelheim
Colorcon
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.